Skip to main content

SABCS Highlights

Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor
Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor
By Hope S. Rugo, MD
Breast Cancer, SABCS 2017 Highlights, SABCS Highlights
Videos
Hope S. Rugo, MD, describes how she would treat a patient with HER-positive metastatic breast cancer that has progressed with a CDK4/CDK6 inhibitor plus an aromatase inhibitor. Read More ›
HER2-Positive Breast Cancer and CDK4/6 Inhibitors
HER2-Positive Breast Cancer and CDK4/6 Inhibitors
By Hope S. Rugo, MD
Breast Cancer, SABCS 2017 Highlights, SABCS Highlights
Videos
Read More ›

Page 3 of 3